Matthew Bashover
Optometrist · Arlington, TXNPI 1689761249
Payments from drug & device makers
Across 103 payments — averaging $69.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$1K
- Bausch & Lomb Americas Inc.$1K
- Sun Pharmaceutical Industries Inc.$610
- Oyster Point Pharma, Inc.$573
- Alcon$539
- LKC Technologies, Inc.$372
- plus $2K from 15 others
What the payments were for
- Food & beverage$7,03899%
- Entertainment$931%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 22 | $1,446 |
| Bausch & Lomb Americas Inc. | 14 | $1,213 |
| Sun Pharmaceutical Industries Inc. | 6 | $610 |
| Oyster Point Pharma, Inc. | 10 | $573 |
| Alcon | 11 | $539 |
| LKC Technologies, Inc. | 4 | $372 |
| Aerie Pharmaceuticals, Inc. | 2 | $289 |
| Tarsus Pharmaceuticals, Inc. | 5 | $283 |
| Glaukos Corporation | 2 | $238 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $227 |
| Coopervision Inc. | 7 | $199 |
| ABB Con-cise Optical Group LLC | 3 | $159 |
| Novartis | 3 | $157 |
| Biotissue Holdings Inc. | 4 | $133 |
| Sanofi | 1 | $122 |
| AbbVie | 1 | $116 |
| Visioneering Technologies, Inc. | 1 | $105 |
| Optos, Inc. | 1 | $93 |
| Ocular Therapeutix, Inc. | 1 | $89 |
| Carl Zeiss Meditec USA, Inc. | 1 | $88 |
| Dompe US, Inc. | 1 | $78 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Acuvue$861
- INFUSE$690
- MIEBO$481
- CEQUA$474
- TYRVAYA$346
- Rhopressa$289
- Rocklatan$289
- XIIDRA$234
- XDEMVY$234
- Precision 1$135
- SPECTACLE LENSES$131
- Contact Lens$131
- PanOptix$131
- MULTI-FOCAL$124
- LUMIZYME$122
- CEREZYME$122
- ALDURAZYME$122
- CERDELGA$122
- FABRAZYME$122
- VUITY$116
How this compares
$7,130 in reported general payments places this provider in the 90th percentile of 4,315 optometrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other optometrist in Arlington
- Tiffany HuynhHouston$3.2M
- Bridgitte LeeHouston$3M
- Bryan FrazierTyler$1.4M
- Derek CunninghamAustin$940K
- Wendy ChungKaty$900K
- Phillip BrunsonHouston$766K
- Claudio LagunasHouston$644K
- Ashley Wallace-TuckerHouston$568K
- Mina VanrachackSan Antonio$553K
- Luis RojasMcKinney$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.